Indigenous–non-Indigenous disparities in health and social outcomes 5 years after first episode psychosis: national cohort study
BJPsych Open · 2025-01 · 11 (1)
DOI: 10.1192/bjo.2024.827 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BJPsych Open, online erschienen am 20.12.2024. Verfasst von Ruth Cunningham und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, University of Otago, Wellington, New Zealand. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
Background
There are ethnic differences, including differences related to indigeneity, in the incidence of first episode psychosis (FEP) and pathways into care, but research on ethnic disparities in outcomes following FEP is limited.
Aims
In this study we examined social and health outcomes following FEP diagnosis for a cohort of Māori (Indigenous people of New Zealand) and non-Māori (non-Indigenous) young people. We have focused on understanding the opportunities for better outcomes for Māori by examining the relative advantage of non-Māori with FEP.
Method
Statistics New Zealand's Integrated Data Infrastructure was accessed to describe mental health and social service interactions and outcomes for a retrospective FEP cohort comprising 918 young Māori and 1275 non-Māori aged 13 to 25 at diagnosis. Logistic regression models were used to examine whether social outcomes including employment, benefit receipt, education and justice involvement in year 5 differed by indigeneity.
Results
Non-Māori young people were more likely than Māori to have positive outcomes in the fifth year after FEP diagnosis, including higher levels of employment and income, and lower rates of benefit receipt and criminal justice system involvement. These patterns were seen across diagnostic groups, and for both those receiving ongoing mental healthcare and those who were not.
Conclusions
Non-Māori experience relative advantage in outcomes 5 years after FEP diagnosis. Indigenous-based social disparities following FEP urgently require a response from the health, education, employment, justice and political systems to avoid perpetuating these inequities, alongside efforts to address the disadvantages faced by all young people with FEP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, University of Otago, Wellington, New Zealand.
- Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
- Department of Māori/Indigenous Health Innovation (MIHI), University of Otago, Christchurch, New Zealand.
- Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
- Specialist Mental Health Service, Te Whatu Ora, Christchurch, New Zealand.
ORCID-Profile: Ruth Cunningham, Richard Porter, Cameron Lacey
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Cunningham, R., Petrović-van der Deen, F., Gibb, S., Crowe, M., Manuel, J., Pitama, S., Crengle, S., Porter, R., & Lacey, C. (2025). Indigenous–non-Indigenous disparities in health and social outcomes 5 years after first episode psychosis: national cohort study. BJPsych Open, 11(1). https://doi.org/10.1192/bjo.2024.827
Vancouver
Cunningham R, Petrović-van der Deen F, Gibb S, Crowe M, Manuel J, Pitama S, et al. Indigenous–non-Indigenous disparities in health and social outcomes 5 years after first episode psychosis: national cohort study. BJPsych Open. 2025;11(1). doi:10.1192/bjo.2024.827
BibTeX
@article{Cunningham2025,
author = {Cunningham, Ruth and Petrović-van der Deen, Frederieke and Gibb, Sheree and Crowe, Marie and Manuel, Jenni and Pitama, Suzanne and Crengle, Sue and Porter, Richard and Lacey, Cameron},
title = {Indigenous–non-Indigenous disparities in health and social outcomes 5 years after first episode psychosis: national cohort study},
journal = {BJPsych Open},
year = {2025},
volume = {11},
number = {1},
doi = {10.1192/bjo.2024.827}
}
EUVIMED